Not on air · 2 of 3 networks checked
Meta Cell Technology
- metacelltech.com
- Medical Equipment Manufacturing
- ES
- 10 employees
Meta Cell Technology’s ads on LinkedIn, Meta and Google, recorded by adsrunning. Browse the latest here for free. Sign up free to see all 20. Watch Meta Cell Technology on any plan to get each new one in your feed.
Watchlist included in every plan
| Network | Status | Live ads | Nov 2025LinkedIn activity · 52 weeksNov 2026 | Checked | Next step |
|---|---|---|---|---|---|
| None recorded | 0 | Checked 4 Nov 2026 | See all 20 ads → | ||
| Meta | Not checked | — | |||
| None recorded | 0 | No ads found on the Google Ads Transparency Center | Checked 3 Nov 2026 | Collect them with the API → |
Meta Cell Technology has no live LinkedIn ads. We recorded no Google ads on 3 Nov 2026.
Latest ads
- LINKEDIN · VIDEOSince 19 Oct 2026
Cuando la respuesta al PRP convencional es parcial, temporal o insuficiente, ¿cuál es el siguiente paso? El Dr. Hany Demian, especialista certificado en dolor, explica dónde puede encajar la señalización por exosomas derivados del PRP en el dolor de columna persistente: selección de pacientes, qué valora antes de tratar y sus límites. 29/10 · 14:00 h · 60 min · online, en inglés con subtítulos en directo en español. Para médicos que infiltran. Gratis. Solo para profesionales sanitarios. Sesión con fines científicos y formativos, que no establece superioridad clínica frente al PRP convencional.
- LINKEDIN · VIDEOSince 19 Oct 2026
Wenn das Ansprechen auf Standard-PRP nur teilweise, vorübergehend oder unzureichend ist: Was kommt danach? Dr. Hany Demian, zertifizierter Schmerzspezialist, erläutert, wo Exosomen-Signalgebung aus PRP bei anhaltenden Wirbelsäulenschmerzen ihren Platz haben kann: Patientenauswahl, was er vorab erfasst und wo Grenzen liegen. 29.10. · 14:00 MEZ · 60 Min. · online, Englisch mit deutschen Live-Untertiteln. Für Ärzte, die injizieren. Kostenlos. Nur für Fachkreise. Diese Veranstaltung dient wissenschaftlichen und Fortbildungszwecken und belegt keine klinische Überlegenheit gegenüber Standard-PRP.
- LINKEDIN · VIDEOSince 19 Oct 2026
When the response to standard PRP is partial, temporary or insufficient, what comes next? Dr Hany Demian, a board-certified pain management specialist, explains where PRP-derived exosome signalling may fit in persistent spine-related pain: patient selection, what he assesses first and where its limits lie. Thursday 29 October · 13:00 UK & Ireland / 14:00 CET · 60 min · online. For clinicians who inject. Registration is free. For healthcare professionals only. This session is intended for scientific and educational purposes and does not establish clinical superiority over standard PRP.
- LINKEDIN · VIDEOSince 19 Oct 2026
Quando a resposta ao PRP convencional é parcial, temporária ou insuficiente, qual o próximo passo? O Dr. Hany Demian, especialista certificado em dor, explica onde a sinalização por exossomos derivados do PRP pode entrar na dor persistente na coluna: seleção de pacientes, o que avalia antes de tratar e os limites. 29/10 · 10h Brasília/13h Lisboa · 60 min · online, em inglês com legendas em português. Para médicos que infiltram. Grátis. Exclusivo para profissionais de saúde. Sessão com finalidade científica e educacional, que não estabelece superioridade clínica em relação ao PRP convencional.
- LINKEDIN · VIDEORecorded 26 Oct 2026
When the response to standard PRP is partial, temporary or insufficient, what comes next? Dr Hany Demian, a board-certified pain management specialist, explains where PRP-derived exosome signalling may fit in persistent spine-related pain: patient selection, what he assesses first and where its limits lie. Thursday 29 October · 17:00 UAE & Oman / 16:00 KSA & Qatar · 60 min · online. For clinicians who inject. Registration is free. For healthcare professionals only. This session is intended for scientific and educational purposes and does not establish clinical superiority over standard PRP.
5 of 20 adsSign up to see every Meta Cell Technology ad, filter by format and date, and get alerts on new ones.
See all 20 adsWatch the companies you care about.
Filter every ad by industry, country, format and network, and get alerts when a company you watch starts running new ads.